Clinical trial
Clinical Study of the BARD® COVERA™ Arteriovenous (AV) Stent Graft
NCT02649946 · C. R. Bard, Industry · Completed
Key facts
| NCT number | NCT02649946 |
|---|---|
| Title | Clinical Study of the BARD® COVERA™ Arteriovenous (AV) Stent Graft |
| Official title | A Prospective, Multi-Center, Randomized, Concurrently-Controlled Clinical Study of the BARD® COVERA™ Arteriovenous (AV) Stent Graft in the Treatment of Stenosis in the Venous Outflow of AV Fistula Access Circuits (AVeNEW) |
| Acronym | AVeNEW |
| Lead sponsor | C. R. Bard, Industry |
| Status | Completed |
| Study type | Interventional |
| Conditions | Stenosis, Restenosis |
| Intervention type | Device, Procedure |
| Interventions | Covera Vascular Covered Stent following PTA, Percutaneous Transluminal Angioplasty (PTA) with Uncoated PTA Balloon |
| Enrollment | 280 |
| Start date | Jun 1, 2016 |
| Primary completion | Aug 1, 2018 |
| Completion | Feb 1, 2021 |
| First posted | Jan 8, 2016 |
| Last update posted | Dec 21, 2021 |
| Countries | Australia, Austria, Belgium, Germany, Netherlands, New Zealand, Switzerland, United States |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: